Form D Explorer

Form D — Porosome Therapeutics, Inc.

0001376474-26-000247 · filed 2026-03-24

Offering

Industry
Biotechnology
Exemptions
06b
Total offering
Total sold
$3,625,000
Minimum investment
$50,000
Investors
Sales commission
Finders' fees

Issuer

Name
Porosome Therapeutics, Inc.
CIK
1934919
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
2021
Address
ONE BOSTON PLACE, STE 2631
BOSTON, MA 02108
Phone
781 956 9799

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View original on SEC EDGAR.